SCHEMBL1850148

SCHEMBL1850148

CC(CC(C)C(N)=O)Nc1ncc(C(N)=O)c(Nc2ccc3nsnc3c2)n1

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SYK P43405 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1846929 0.89 SYK (0.77) SYK
SCHEMBL1353768 0.87 SYK (1.00) SYK
SCHEMBL1353771 0.87 SYK (1.00) SYK
SCHEMBL1847256 0.85 SYK (0.78) SYK
SCHEMBL1848661 0.80 SYK (0.76) SYK
SCHEMBL13624873 0.79 SYK (0.66) SYK
SCHEMBL1852111 0.79 SYK (0.61) SYK
SCHEMBL1851587 0.79 SYK (0.77) SYK
SCHEMBL1848374 0.78 SYK (0.79) SYK
SCHEMBL1354339 0.76 SYK (1.00) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323993-A2 2,6-DIAMINO- PYRIMIDIN- 5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS Portola Pharmaceuticals, Inc. (US) 2011-05-25 EP disclosed
WO-2009136995-A2 INHIBITORS OF SYK PROTEIN KINASE PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-12 WO disclosed